ClinicalTrials.Veeva

Menu

Self-management and Quality of Life in Individuals With Type 2 Diabetes Mellitus

A

Afyonkarahisar Health Sciences University

Status

Completed

Conditions

Pre-Existing Type 2 Diabetes Mellitus

Treatments

Other: Education

Study type

Interventional

Funder types

Other

Identifiers

NCT05983120
Afyonkarahisar HSU

Details and patient eligibility

About

The study was conducted in order to study the effect of the training given according to social-cognitive learning theory (SCLT) upon diabetes self-management and quality of life among type 2 diabetes mellitus individuals.

Full description

The study was done as a randomized-controlled experimental study at Internal Diseases Polyclinics of Afyonkarahisar Public Hospital between November 2021 and August 2022. The study was completed with 60 patients -experimental group (30 patients) and control group (30 patients)- who met inclusion criteria. The data were gathered using Information Request Form and Metabolic Variables Form, Diabetes Self-Management Scale (DSMS) for Type 2 Diabetic Patients, Multidimensional Scale of Perceived Social Support (MSPSS), Type 2 Diabetes Mellitus Self-Management Questionnaire (SMQ), WHOQOL-BREF (WHO- Quality of Life Scale- Short form). A theoretical and practical training based on SCLT was provided to the experimental group for the first five weeks -one module for each week- through power point presentations and afterwards, SMS reminders were sent every fifteen days for seven weeks and at the end of the twelfth week the training was completed. The control group received a standard training from diabetes nurse. The data were assessed using statistical methods.

Enrollment

60 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • 18 years and over
  • Being diagnosed with Type 2 diabetes mellitus,
  • Being on insulin therapy,
  • Being open to verbal communication,
  • Being literate
  • Not to have an obstacle to continue the implementation phase of the research (for example, pregnancy plan, changing province, etc.)
  • Not having hearing-vision problems and diabetes-related serious neuropathy (amputation, etc.),
  • Patients who agreed to participate in the study.

Exclusion Criteria:The patient has a perception disorder and psychiatric disorder that prevents communication,

  • Being pregnant,
  • Individuals with serious complications such as retinopathy and neuropathy at the level of blindness were excluded from the study.

Research Termination Criteria

  • Not performing the specified applications properly during the study,
  • Unreachable in follow-ups,
  • Those who want to quit working,
  • Serious complications related to comorbid diseases and diabetes that occur during the working process,
  • The study was terminated with patients who were moved out of the province during the study.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Training group
Experimental group
Description:
In the first five weeks, the experimental group was given training consisting of five modules, accompanied by power point presentations and applied social cognitive learning theory, then SMS reminders were sent every fortnight for seven weeks, and the study was completed at the end of the twelfth week. The control group received standard training from a diabetes nurse. Scale evaluations, metabolic and anthropometric measurements were made at the beginning and end of the study in the experimental and control groups. In addition, the scale evaluation was repeated in the fifth week for the experimental group. Data were evaluated using appropriate statistical methods.
Treatment:
Other: Education
Control Group
No Intervention group
Description:
The control group received standard training from a diabetes nurse.

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems